Annual Total Assets:
$22.53B-$197.00M(-0.87%)Summary
- As of April 2, 2025, VRTX annual total assets is $22.53 billion, with the most recent change of -$197.00 million (-0.87%) on December 31, 2024.
- During the last 3 years, VRTX annual total assets has risen by +$9.10 billion (+67.75%).
- VRTX annual total assets is now -0.87% below its all-time high of $22.73 billion, reached on December 31, 2023.
Performance
VRTX Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Assets:
$22.53B+$293.00M(+1.32%)Summary
- As of April 2, 2025, VRTX quarterly total assets is $22.53 billion, with the most recent change of +$293.00 million (+1.32%) on December 31, 2024.
- Over the past year, VRTX quarterly total assets has stayed the same.
- VRTX quarterly total assets is now -5.79% below its all-time high of $23.92 billion, reached on March 31, 2024.
Performance
VRTX Quarterly Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Assets Formula
Total Assets = Current Assets + Non-Current Assets
VRTX Total Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -0.9% | 0.0% |
| 3 y3 years | +67.8% | +34.9% |
| 5 y5 years | +170.9% | +34.9% |
VRTX Total Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -0.9% | +67.8% | -5.8% | +58.1% |
| 5 y | 5-year | -0.9% | +170.9% | -5.8% | +153.4% |
| alltime | all time | -0.9% | >+9999.0% | -5.8% | >+9999.0% |
Vertex Pharmaceuticals Incorporated Total Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $22.53B(-0.9%) | $22.53B(+1.3%) |
| Sep 2024 | - | $22.24B(+10.5%) |
| Jun 2024 | - | $20.13B(-15.8%) |
| Mar 2024 | - | $23.92B(+5.2%) |
| Dec 2023 | $22.73B(+25.2%) | $22.73B(+4.6%) |
| Sep 2023 | - | $21.73B(+6.8%) |
| Jun 2023 | - | $20.35B(+7.2%) |
| Mar 2023 | - | $18.97B(+4.5%) |
| Dec 2022 | $18.15B(+35.1%) | $18.15B(+8.6%) |
| Sep 2022 | - | $16.71B(+7.2%) |
| Jun 2022 | - | $15.58B(+9.3%) |
| Mar 2022 | - | $14.26B(+6.1%) |
| Dec 2021 | $13.43B(+14.3%) | $13.43B(+6.4%) |
| Sep 2021 | - | $12.62B(+3.2%) |
| Jun 2021 | - | $12.22B(+0.9%) |
| Mar 2021 | - | $12.12B(+3.1%) |
| Dec 2020 | $11.75B(+41.3%) | $11.75B(+4.0%) |
| Sep 2020 | - | $11.30B(+10.6%) |
| Jun 2020 | - | $10.22B(+14.9%) |
| Mar 2020 | - | $8.89B(+6.9%) |
| Dec 2019 | $8.32B(+33.2%) | $8.32B(+10.7%) |
| Sep 2019 | - | $7.51B(+6.8%) |
| Jun 2019 | - | $7.03B(+7.5%) |
| Mar 2019 | - | $6.54B(+4.8%) |
| Dec 2018 | $6.25B(+76.1%) | $6.25B(+35.2%) |
| Sep 2018 | - | $4.62B(+6.6%) |
| Jun 2018 | - | $4.34B(+9.7%) |
| Mar 2018 | - | $3.95B(+11.5%) |
| Dec 2017 | $3.55B(+22.4%) | $3.55B(+10.9%) |
| Sep 2017 | - | $3.20B(-2.7%) |
| Jun 2017 | - | $3.29B(+11.5%) |
| Mar 2017 | - | $2.95B(+1.7%) |
| Dec 2016 | $2.90B(+15.9%) | $2.90B(+11.0%) |
| Sep 2016 | - | $2.61B(+2.4%) |
| Jun 2016 | - | $2.55B(+2.5%) |
| Mar 2016 | - | $2.49B(-0.4%) |
| Dec 2015 | $2.50B(+7.0%) | $2.50B(+2.7%) |
| Sep 2015 | - | $2.43B(+2.5%) |
| Jun 2015 | - | $2.37B(+9.6%) |
| Mar 2015 | - | $2.17B(-7.2%) |
| Dec 2014 | $2.33B(+0.7%) | $2.33B(-3.0%) |
| Sep 2014 | - | $2.41B(+13.6%) |
| Jun 2014 | - | $2.12B(-3.6%) |
| Mar 2014 | - | $2.20B(-5.3%) |
| Dec 2013 | $2.32B(-16.0%) | $2.32B(-10.2%) |
| Sep 2013 | - | $2.58B(-0.1%) |
| Jun 2013 | - | $2.58B(+8.0%) |
| Mar 2013 | - | $2.39B(-13.3%) |
| Dec 2012 | $2.76B(+25.2%) | $2.76B(+1.5%) |
| Sep 2012 | - | $2.72B(+4.4%) |
| Jun 2012 | - | $2.60B(+11.0%) |
| Mar 2012 | - | $2.35B(+6.4%) |
| Dec 2011 | $2.20B(+27.8%) | $2.20B(+5.4%) |
| Sep 2011 | - | $2.09B(+18.7%) |
| Jun 2011 | - | $1.76B(+14.6%) |
| Mar 2011 | - | $1.54B(-10.8%) |
| Dec 2010 | $1.73B(-11.8%) | $1.73B(-8.6%) |
| Sep 2010 | - | $1.89B(+14.2%) |
| Jun 2010 | - | $1.65B(-6.6%) |
| Mar 2010 | - | $1.77B(-9.5%) |
| Dec 2009 | $1.96B(+99.4%) | $1.96B(+24.3%) |
| Sep 2009 | - | $1.57B(+9.3%) |
| Jun 2009 | - | $1.44B(-8.0%) |
| Mar 2009 | - | $1.57B(+59.7%) |
| Dec 2008 | $980.48M(+63.0%) | $980.48M(-8.2%) |
| Sep 2008 | - | $1.07B(+10.0%) |
| Jun 2008 | - | $970.80M(+9.1%) |
| Mar 2008 | - | $889.50M(+47.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2007 | $601.48M(-34.7%) | $601.48M(-8.2%) |
| Sep 2007 | - | $655.15M(-13.9%) |
| Jun 2007 | - | $761.07M(-8.9%) |
| Mar 2007 | - | $835.10M(-9.4%) |
| Dec 2006 | $921.58M(+67.9%) | $921.58M(+2.2%) |
| Sep 2006 | - | $902.11M(+44.2%) |
| Jun 2006 | - | $625.48M(+19.2%) |
| Mar 2006 | - | $524.66M(-4.4%) |
| Dec 2005 | $549.00M(+0.6%) | $549.00M(-0.3%) |
| Sep 2005 | - | $550.58M(-7.8%) |
| Jun 2005 | - | $596.90M(+23.3%) |
| Mar 2005 | - | $484.23M(-11.2%) |
| Dec 2004 | $545.45M(-24.7%) | $545.45M(-5.0%) |
| Sep 2004 | - | $574.36M(-8.0%) |
| Jun 2004 | - | $624.05M(-6.7%) |
| Mar 2004 | - | $669.19M(-7.6%) |
| Dec 2003 | $724.41M(-11.2%) | $724.41M(-2.5%) |
| Sep 2003 | - | $742.68M(-5.7%) |
| Jun 2003 | - | $787.46M(-6.3%) |
| Mar 2003 | - | $840.31M(+3.0%) |
| Dec 2002 | $815.72M(-11.8%) | $815.72M(-1.8%) |
| Sep 2002 | - | $831.07M(-3.4%) |
| Jun 2002 | - | $860.47M(-1.7%) |
| Mar 2002 | - | $875.51M(-5.4%) |
| Dec 2001 | $925.13M(-1.7%) | $925.13M(+0.3%) |
| Sep 2001 | - | $922.37M(+20.3%) |
| Jun 2001 | - | $766.83M(-0.4%) |
| Mar 2001 | - | $769.54M(-18.2%) |
| Dec 2000 | $941.14M(+304.9%) | $941.14M(+21.5%) |
| Sep 2000 | - | $774.56M(+80.8%) |
| Jun 2000 | - | $428.32M(+7.9%) |
| Mar 2000 | - | $396.93M(+70.8%) |
| Dec 1999 | $232.44M(-12.7%) | $232.44M(+3.4%) |
| Sep 1999 | - | $224.80M(-5.8%) |
| Jun 1999 | - | $238.60M(-4.4%) |
| Mar 1999 | - | $249.70M(-6.2%) |
| Dec 1998 | $266.30M(-9.9%) | $266.30M(-4.2%) |
| Sep 1998 | - | $277.90M(+1.1%) |
| Jun 1998 | - | $274.90M(-3.0%) |
| Mar 1998 | - | $283.30M(-4.2%) |
| Dec 1997 | $295.60M(+106.0%) | $295.60M(-1.0%) |
| Sep 1997 | - | $298.70M(-0.7%) |
| Jun 1997 | - | $300.70M(+3.8%) |
| Mar 1997 | - | $289.60M(+101.8%) |
| Dec 1996 | $143.50M(+44.9%) | $143.50M(0.0%) |
| Sep 1996 | - | $143.50M(+94.7%) |
| Jun 1996 | - | $73.70M(-18.4%) |
| Mar 1996 | - | $90.30M(-8.8%) |
| Dec 1995 | $99.00M(-14.8%) | $99.00M(+0.7%) |
| Sep 1995 | - | $98.30M(-7.4%) |
| Jun 1995 | - | $106.10M(-5.1%) |
| Mar 1995 | - | $111.80M(-3.8%) |
| Dec 1994 | $116.20M(+90.5%) | $116.20M(+8.9%) |
| Sep 1994 | - | $106.70M(-3.4%) |
| Jun 1994 | - | $110.40M(-3.1%) |
| Mar 1994 | - | $113.90M(+86.7%) |
| Dec 1993 | $61.00M(+19.6%) | $61.00M(+20.1%) |
| Sep 1993 | - | $50.80M(-1.6%) |
| Jun 1993 | - | $51.60M(+6.0%) |
| Mar 1993 | - | $48.70M(-4.5%) |
| Dec 1992 | $51.00M(-10.7%) | $51.00M(-3.6%) |
| Sep 1992 | - | $52.90M(-2.9%) |
| Jun 1992 | - | $54.50M(-1.8%) |
| Mar 1992 | - | $55.50M(-2.8%) |
| Dec 1991 | $57.10M(+520.7%) | $57.10M(+76.2%) |
| Sep 1991 | - | $32.40M(+343.8%) |
| Jun 1991 | - | $7.30M(-20.7%) |
| Dec 1990 | $9.20M | $9.20M |
FAQ
- What is Vertex Pharmaceuticals Incorporated annual total assets?
- What is the all time high annual total assets for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated annual total assets year-on-year change?
- What is Vertex Pharmaceuticals Incorporated quarterly total assets?
- What is the all time high quarterly total assets for Vertex Pharmaceuticals Incorporated?
- What is Vertex Pharmaceuticals Incorporated quarterly total assets year-on-year change?
What is Vertex Pharmaceuticals Incorporated annual total assets?
The current annual total assets of VRTX is $22.53B
What is the all time high annual total assets for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high annual total assets is $22.73B
What is Vertex Pharmaceuticals Incorporated annual total assets year-on-year change?
Over the past year, VRTX annual total assets has changed by -$197.00M (-0.87%)
What is Vertex Pharmaceuticals Incorporated quarterly total assets?
The current quarterly total assets of VRTX is $22.53B
What is the all time high quarterly total assets for Vertex Pharmaceuticals Incorporated?
Vertex Pharmaceuticals Incorporated all-time high quarterly total assets is $23.92B
What is Vertex Pharmaceuticals Incorporated quarterly total assets year-on-year change?
Over the past year, VRTX quarterly total assets has changed by $0.00 (0.00%)